| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H26N2O |
| Molecular Weight | 310.4332 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@H]3C[C@H](CC)[C@]1([H])[N@](C3)CCC4=C2NC5=C4C=C(OC)C=C5
InChI
InChIKey=HSIBGVUMFOSJPD-CFDPKNGZSA-N
InChI=1S/C20H26N2O/c1-3-13-8-12-9-17-19-15(6-7-22(11-12)20(13)17)16-10-14(23-2)4-5-18(16)21-19/h4-5,10,12-13,17,20-21H,3,6-9,11H2,1-2H3/t12-,13+,17+,20+/m1/s1
| Molecular Formula | C20H26N2O |
| Molecular Weight | 310.4332 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 2.0 µM [Ki] | |||
| 130.0 nM [Ki] | |||
| 1.0 µM [Ki] | |||
| 9.0 µM [Ki] | |||
| 0.09 µM [Ki] | |||
| 2.0 µM [Ki] | |||
| 0.5 µM [Ki] | |||
| 0.95 µM [IC50] |
